Page last updated: 2024-09-04

docetaxel anhydrous and 7-benzyloxy-4-trifluoromethylcoumarin

docetaxel anhydrous has been researched along with 7-benzyloxy-4-trifluoromethylcoumarin in 1 studies

Compound Research Comparison

Studies
(docetaxel anhydrous)
Trials
(docetaxel anhydrous)
Recent Studies (post-2010)
(docetaxel anhydrous)
Studies
(7-benzyloxy-4-trifluoromethylcoumarin)
Trials
(7-benzyloxy-4-trifluoromethylcoumarin)
Recent Studies (post-2010) (7-benzyloxy-4-trifluoromethylcoumarin)
12,1103,2166,9202809

Protein Interaction Comparison

ProteinTaxonomydocetaxel anhydrous (IC50)7-benzyloxy-4-trifluoromethylcoumarin (IC50)
Androgen receptorHomo sapiens (human)1.18
Amine oxidase [flavin-containing] BRattus norvegicus (Norway rat)1.3804

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bank, PC; Beijnen, JH; Hendrikx, JJ; Maas-Bakker, RF; Meijerman, I; Mooiman, KD; Rosing, H; Schellens, JH1

Other Studies

1 other study(ies) available for docetaxel anhydrous and 7-benzyloxy-4-trifluoromethylcoumarin

ArticleYear
The effect of complementary and alternative medicines on CYP3A4-mediated metabolism of three different substrates: 7-benzyloxy-4-trifluoromethyl-coumarin, midazolam and docetaxel.
    The Journal of pharmacy and pharmacology, 2014, Volume: 66, Issue:6

    Topics: Complementary Therapies; Coumarins; Cytochrome P-450 CYP3A; Docetaxel; Ginkgo biloba; Grape Seed Extract; Humans; Microsomes, Liver; Midazolam; Silybum marianum; Taxoids; Tea

2014